Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals fits that bill despite its more than $26 billion market cap. Is it possible that some real good…
As mortgage rates have inched higher, mortgage loan credit risk has also increased. New data from CoreLogic indicates that risk was up 3.6 percentage points year over year in the first quarter.
Egalet saw its shares take a dive early on Tuesday after the company announced that it received a complete response letter FDA in regards to its chronic pain treatment.
In a new Jefferies research report, the oilfield services team focuses on the pressure pumpers and the frac sand companies, as they feel they offer investors more cushion within the sector to a decline…
The top analyst upgrades, downgrades and other research calls from Tuesday include American Express, ADP, Goodyear Tire, McDonald's, National Oilwell Varco, NVIDIA and Vivint Solar.
Akcea Therapeutics expects to price more than 9 million shares in the range of $12 to $14 apiece in an initial public offering valued up to almost $155 million.
Cybersecurity is more critical now and going forward than ever before, and some of the top companies remain cheap. The upside for investors is clearly there.
Boeing continues to pile up orders and commitments for its new 737 MAX 10, but today's big news from the company is expected to center on new details about a proposed, but not announced,…
A former Barclays CEO and others have been charged with fraud-related legal violations, Time Warner announced a partnership with Snap, and UPS will raise holiday shipping rates.
Monday was an incredibly positive day for the markets with the Dow and S&P 500 hitting all-time highs in the session and the Nasdaq having one of its best trading days this year. Although…